Application Note: Determination of amino acids for myocardial infarction and diabetes type 2
21 January 2021

In this application note, MembraPure GmbH demonstrates a method for the determination of amino acids, such as homocysteine, which at elevated levels is a known marker of risk of cardiovascular disease.